US Stock MarketDetailed Quotes
CODX Co-diagnostics
- 1.200
- +0.010+0.84%
Close May 2 16:00 ET
- 1.170
- -0.030-2.50%
Post 18:17 ET
37.51MMarket Cap-1000P/E (TTM)
1.200High1.150Low32.83KVolume1.190Open1.190Pre Close38.87KTurnover0.11%Turnover RatioLossP/E (Static)31.26MShares1.89052wk High0.44P/B36.50MFloat Cap0.97552wk Low--Dividend TTM30.41MShs Float30.990Historical High--Div YieldTTM4.20%Amplitude0.694Historical Low1.184Avg Price1Lot Size
About Co-diagnostics Company
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolCODX
Company NameCo-diagnostics
Listing DateJul 12, 2017
Issue Price6.00
Founded2013
CEOMr. Dwight H Egan
MarketNASDAQ
Employees155
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2401 South Foothill Drive,Suite D
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84109
Phone1-801-438-1036
Websitehttp://www.codiagnostics.com
Company Executives
- Name
- Position
- Salary
- Dwight H Egan
- Chief Executive Officer, President and Chairman of the Board
- 1.97M
- Brian L. Brown
- Corporate Secretary, Chief Financial Officer and Principal Accounting Officer
- 1.58M
- Richard Abbott
- President
- --
- James B. Nelson
- Independent Director
- 516.60K
- Richard S. Serbin
- Independent Director
- 516.60K
- Edward L. Murphy
- Independent Director
- 516.60K
- Dr. Eugene Durenard, Pd.D
- Independent Director
- 516.60K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg